Matthias Augustin

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

Kenneth B. Gordon, Bruce Strober, Mark Lebwohl et al. · The Lancet · 2018 · 662 citations

Medicine, Clinical Sciences, Pharmacotherapy +11

Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus

N.Q. Phan, Christine Blome, Fleur Fritz et al. · Acta Dermato Venereologica · 2012 · 571 citations · Full text

Social Sciences, Psychology, Physical Examination +8

Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus

Adam Reich, Monika Heisig, N.Q. Phan et al. · Acta Dermato Venereologica · 2012 · 493 citations · Full text

Nursing, Dermatology, Physical Examination +14

Epidemiology and comorbidity of psoriasis in children

Matthias Augustin, Gerd Glaeske, Marc Alexander Radtke et al. · British Journal of Dermatology · 2009 · 492 citations

Medicine, Dermatology, Pediatrics +7

Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis

Kristian Reich, Karsten Krüger, Matthias Augustin · British Journal of Dermatology · 2009 · 392 citations

Medicine, Clinical Sciences, Dermatology +12